Scarffe H - Search Results

1

Pharmacokinetics of a hematoregulatory peptide (SK&F107647) in healthy male volunteers and in patients with colorectal or pancreatic adenocarcinoma not amenable to standard therapy.

Zia-Amirhosseini P, Harris RZ, Cowley HC, Valle JW, Citerone DR, Boppana VK, Scarffe H, Watson P, Davis CB. Zia-Amirhosseini P, et al. Among authors: scarffe h. Pharm Res. 2000 Apr;17(4):385-90. doi: 10.1023/a:1007512617139. Pharm Res. 2000. PMID: 10870980

2

Treatment of a pancreatic tumour secreting parathyroid hormone related protein.

Dodwell D, Gurney H, Scarffe H, Abbas S. Dodwell D, et al. Among authors: scarffe h. BMJ. 1990 Jun 23;300(6740):1653. doi: 10.1136/bmj.300.6740.1653. BMJ. 1990. PMID: 2372652 Free PMC article. No abstract available.

3

A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial).

Mead GM, Barrans SL, Qian W, Walewski J, Radford JA, Wolf M, Clawson SM, Stenning SP, Yule CL, Jack AS; UK National Cancer Research Institute Lymphoma Clinical Studies Group; Australasian Leukaemia and Lymphoma Group. Mead GM, et al. Blood. 2008 Sep 15;112(6):2248-60. doi: 10.1182/blood-2008-03-145128. Epub 2008 Jul 8. Blood. 2008. PMID: 18612102 Free PMC article. Clinical Trial.

4

Randomised vehicle-controlled dose-finding study of glycosylated recombinant human granulocyte colony-stimulating factor after bone marrow transplantation.

Linch DC, Scarffe H, Proctor S, Chopra R, Taylor PR, Morgenstern G, Cunningham D, Burnett AK, Cawley JC, Franklin IM, et al. Linch DC, et al. Among authors: scarffe h. Bone Marrow Transplant. 1993 Apr;11(4):307-11. Bone Marrow Transplant. 1993. PMID: 7683552 Clinical Trial.

5

A phase I study of rDNA alpha-2b interferon as a 6-week continuous intravenous infusion.

Smith D, Wagstaff J, Thatcher N, Scarffe H. Smith D, et al. Among authors: scarffe h. Cancer Chemother Pharmacol. 1987;20(4):327-31. doi: 10.1007/BF00262586. Cancer Chemother Pharmacol. 1987. PMID: 3690806

6

VAP-cyclo: a short intensive regimen of chemotherapy for advanced breast cancer.

Bramwell VH, Howell A, Scarffe H, Crowther D, Sellwood RA. Bramwell VH, et al. Among authors: scarffe h. Cancer Treat Rep. 1982 Nov;66(11):1999-2000. Cancer Treat Rep. 1982. PMID: 6897207 No abstract available.

7

Repeated investigations of cyclophosphamide disposition in myeloma patients receiving intermittent chemotherapy.

Edwards G, Calvert RT, Crowther D, Bramwell V, Scarffe H. Edwards G, et al. Among authors: scarffe h. Br J Clin Pharmacol. 1980 Sep;10(3):281-5. doi: 10.1111/j.1365-2125.1980.tb01756.x. Br J Clin Pharmacol. 1980. PMID: 7437246 Free PMC article.

8

The disposition of cyclophosphamide in a group of myeloma patients.

Bramwell V, Calvert RT, Edwards G, Scarffe H, Crowther D. Bramwell V, et al. Among authors: scarffe h. Cancer Chemother Pharmacol. 1979;3(4):253-9. doi: 10.1007/BF00254741. Cancer Chemother Pharmacol. 1979. PMID: 535136

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters